Stay updated on Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial page.

Latest updates to the Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2. Removed the older PubMed note and the v3.2.0 revision.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding status banner from the page. The banner did not influence the study data or page functionality.SummaryDifference0.2%

- Check42 days agoChange DetectedBoth screenshots reflect the same study details, including title, design, outcomes, and locations; only layout and formatting appear to differ. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference3%

- Check78 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%

- Check92 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed.SummaryDifference0.2%

Stay in the know with updates to Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial page.